Skip to content

Jhunjhunwala backed Concord Biotech sets IPO price band at Rs 705-741

The IPO consists of a pure offer for sale of upto 20.93 million shares by Helix Investment Holdings Pte Ltd

Read More

​ The IPO consists of a pure offer for sale of upto 20.93 million shares by Helix Investment Holdings Pte Ltd The IPO consists of a pure offer for sale of upto 20.93 million shares by Helix Investment Holdings Pte Ltd  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish